Medicamen Biotech Limited (BOM:531146)

Medicamen Biotech Revenue

Medicamen Biotech had revenue of 487.59M INR in the quarter ending June 30, 2026, with 12.05% growth. This brings the company's revenue in the last twelve months to 2.06B, up 22.21% year-over-year. In the fiscal year ending March 31, 2026, Medicamen Biotech had annual revenue of 2.01B with 19.90% growth.

• Revenue (ttm): 2.06B
• Revenue Growth: +22.21%
• P/S Ratio: 1.37
• Revenue / Employee: 5.48M
• Employees: 376
• Market Cap: 2.82B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	2.01B	333.36M	19.90%
Mar 31, 2025	1.68B	-117.59M	-6.56%
Mar 31, 2024	1.79B	384.39M	27.29%
Mar 31, 2023	1.41B	254.22M	22.02%
Mar 31, 2022	1.15B	27.29M	2.42%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 17, 2026

Data Sources Report a data error